GATA3 and breast cancer: On the other hand, 82% (n = 17) of p18mt;Gata3+/- mammary tumors were highly heterogeneous, poorly-differentiated, ER negative, Ck5, Ck14 or SMA positive basal-like tumors (Table 1, Figure 2B-E).